• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤中的树突状细胞——在黑色素瘤治疗中的潜在用途。

Dendritic cells in the skin--potential use for melanoma treatment.

作者信息

El Marsafy Sanaa, Bagot Martine, Bensussan Armand, Mauviel Alain

机构信息

INSERM U 697, Paris, France.

出版信息

Pigment Cell Melanoma Res. 2009 Feb;22(1):30-41. doi: 10.1111/j.1755-148X.2008.00532.x. Epub 2008 Nov 27.

DOI:10.1111/j.1755-148X.2008.00532.x
PMID:19040502
Abstract

Melanoma is an aggressive malignancy with poor prognosis. Eradication of tumor cells requires an effective interaction between melanoma cells and different players of the immune system. As the most potent professional antigen-presenting cells, dendritic cells (DCs) play a pivotal role in mounting a specific immune response where their intratumoral and peritumoral density as well as their functional status are correlated with clinical staging of the disease and with patients' survival. Under steady-state conditions, internalization of apoptotic cells by immature DCs designates a state of tolerance to self-antigens. Nevertheless, pathogens and necrotic cells interacting with pattern recognition receptors trigger downstream signaling pathways that evoke maturation of DCs, leading to the production of pro-inflammatory cytokines. These mature DCs are essential for T-cell priming and subsequent development of a specific immune response. Altered functions of DCs have an impact on the development of various disorders including autoimmune diseases and cancers. Herein, we focus on the checkpoints created throughout DCs antigen capturing and presentation to T cells, with subsequent development of either tolerance or immune response, with an emphasis on the role played by DCs in melanoma tumorigenesis and their therapeutic potential.

摘要

黑色素瘤是一种侵袭性恶性肿瘤,预后较差。根除肿瘤细胞需要黑色素瘤细胞与免疫系统的不同参与者之间进行有效的相互作用。作为最强大的专职抗原呈递细胞,树突状细胞(DCs)在引发特异性免疫反应中起关键作用,其肿瘤内和肿瘤周围的密度以及功能状态与疾病的临床分期和患者的生存率相关。在稳态条件下,未成熟DCs内化凋亡细胞表明对自身抗原处于耐受状态。然而,病原体和坏死细胞与模式识别受体相互作用会触发下游信号通路,引发DCs的成熟,导致促炎细胞因子的产生。这些成熟的DCs对于T细胞启动和随后特异性免疫反应的发展至关重要。DCs功能的改变会影响包括自身免疫性疾病和癌症在内的各种疾病的发展。在此,我们关注在DCs捕获抗原并呈递给T细胞的整个过程中产生的检查点,以及随后耐受或免疫反应的发展,重点是DCs在黑色素瘤肿瘤发生中的作用及其治疗潜力。

相似文献

1
Dendritic cells in the skin--potential use for melanoma treatment.皮肤中的树突状细胞——在黑色素瘤治疗中的潜在用途。
Pigment Cell Melanoma Res. 2009 Feb;22(1):30-41. doi: 10.1111/j.1755-148X.2008.00532.x. Epub 2008 Nov 27.
2
Presence and maturity of dendritic cells in melanoma lymph node metastases.黑色素瘤淋巴结转移灶中树突状细胞的存在情况及成熟度
J Pathol. 2005 Sep;207(1):83-90. doi: 10.1002/path.1809.
3
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.接受树突状细胞疫苗接种的黑色素瘤患者的长期存活与肿瘤特异性迟发型IV型超敏反应以及表达肿瘤生长因子β的T细胞数量减少相关。
J Clin Oncol. 2009 Feb 20;27(6):945-52. doi: 10.1200/JCO.2008.18.0794. Epub 2009 Jan 12.
4
The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.在使用树突状细胞的肿瘤免疫治疗中,通过主要组织相容性复合体II类诱导肿瘤特异性CD4+ T细胞是获得针对B16黑色素瘤细胞系的最佳抗肿瘤免疫力所必需的。
Exp Dermatol. 2009 Apr;18(4):396-403. doi: 10.1111/j.1600-0625.2008.00802.x. Epub 2008 Oct 23.
5
Dendritic cells from bench to bedside and back.从实验台到临床再回归:树突状细胞
Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31.
6
[Dendritic cells--a new weapon in therapy of melanoma?].[树突状细胞——黑色素瘤治疗的新武器?]
Hautarzt. 1996 Jun;47(6):488-90.
7
Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.与浸润原发性皮肤黑色素瘤的活化T淋巴细胞相结合的DC-LAMP(+)成熟树突状细胞密度是一个强有力的独立预后因素。
Cancer Immunol Immunother. 2007 Sep;56(9):1459-69. doi: 10.1007/s00262-007-0286-3. Epub 2007 Feb 6.
8
Dendritic cells: immune regulators in health and disease.树突状细胞:健康与疾病中的免疫调节因子
Physiol Rev. 2002 Jan;82(1):97-130. doi: 10.1152/physrev.00023.2001.
9
Increased survival from stage IV melanoma associated with fewer regulatory T Cells.IV期黑色素瘤患者生存率提高与调节性T细胞数量减少有关。
J Surg Res. 2009 Jun 1;154(1):13-20. doi: 10.1016/j.jss.2008.04.043. Epub 2008 Jun 2.
10
Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.共刺激配体CD70在稳态树突状细胞上的表达打破了CD8⁺T细胞的耐受性并允许有效的免疫反应。
Immunity. 2008 Dec 19;29(6):934-46. doi: 10.1016/j.immuni.2008.10.009. Epub 2008 Dec 8.

引用本文的文献

1
Treatment resistance to melanoma therapeutics on a single cell level.在单细胞水平上治疗黑色素瘤治疗药物的耐药性。
Sci Rep. 2024 Sep 19;14(1):21915. doi: 10.1038/s41598-024-72255-9.
2
Tumor infiltrating lymphocytes: The regulator of melanoma evolution.肿瘤浸润淋巴细胞:黑色素瘤演变的调节因子。
Oncol Lett. 2019 May;17(5):4155-4161. doi: 10.3892/ol.2019.9940. Epub 2019 Jan 16.
3
Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.人皮肤鳞状细胞癌中的朗格汉斯细胞可诱导强烈的 1 型免疫。
J Invest Dermatol. 2012 Jun;132(6):1645-55. doi: 10.1038/jid.2012.34. Epub 2012 Mar 8.
4
Local response to microneedle-based influenza immunization in the skin.基于微针的皮肤流感免疫的局部反应。
mBio. 2012 Mar 6;3(2):e00012-12. doi: 10.1128/mBio.00012-12. Print 2012.
5
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.NK1.1 细胞和 CD8 T 细胞介导 Cl-IB-MECA 在小鼠黑色素瘤模型中的抗肿瘤活性。
Neoplasia. 2011 Apr;13(4):365-73. doi: 10.1593/neo.101628.
6
Effects of immunomodulatory drugs on TNF-α and IL-12 production by purified epidermal langerhans cells and peritoneal macrophages.免疫调节药物对纯化的表皮朗格汉斯细胞和腹腔巨噬细胞产生肿瘤坏死因子-α和白细胞介素-12的影响。
BMC Res Notes. 2011 Jan 28;4:24. doi: 10.1186/1756-0500-4-24.